Determining the risk of bleeding in warfarin therapy.
Ebell
M H
MH
Michigan State University, East Lansing, USA. mark.ebell@ht.msu.edu
D000925:Anticoagulants / Q000009:adverse effects*; D005260:Female; D005544:Forecasting; D006470:Hemorrhage / Q000139:chemically induced* / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D015203:Reproducibility of Results; D012307:Risk Factors; D013923:Thromboembolism / Q000188:drug therapy*; D014859:Warfarin / Q000009:adverse effects*
D000925:Anticoagulants; D014859:Warfarin